Viral Infections and Cutaneous Drug-Related Eruptions

被引:21
作者
Anci, Eleonora [1 ,2 ]
Braun, Camille [1 ,2 ,3 ]
Marinosci, Annalisa [1 ,2 ]
Rodieux, Frederique [4 ]
Midun, Elise [1 ,2 ,3 ]
Torres, Maria-Jose [5 ]
Caubet, Jean-Christoph [1 ,2 ]
机构
[1] Univ Hosp Geneva, Pediat Allergy Unit, Geneva, Switzerland
[2] Univ Geneva, Geneva, Switzerland
[3] Univ Lyon 1 Claude Bernard, Pediat Allergy Unit, Villeurbanne, France
[4] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland
[5] Univ Malaga, Hosp Reg Univ Malaga, Allergy Unit, Malaga, Spain
关键词
drug; hypersensitivity; allergy; virus; mechanism;
D O I
10.3389/fphar.2020.586407
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the general population, up to 10% of children treated by antibiotics have cutaneous adverse drug reaction, but allergy is confirmed in less than 20% of patients. Most of the non-allergic reactions are probably due to virus, such as enterovirus acute infection or Ebstein-Barr Virus (EBV) acute infection or reactivation. Especially in children, viruses have the propensity to induce skin lesions (maculopapular rash, urticaria) due to their skin infiltration or immunologic response. In drug-related skin eruptions, a virus can participate by activating an immune predisposition. The culprit antibiotic is then the trigger for reacting. Even in severe drug-induced reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, viruses take part in immune phenomena, especially herpes viruses. Understanding the mechanisms of both virus- and drug-induced skin reaction is important to develop our clinical reflection and give an adaptive care to the patient. Our aim is to review current knowledge on the different aspects and potential roles of viruses in the different type of drug hypersensitivity reactions (DHR). Although major advances have been made those past year, further studies are needed for a better understanding of the link between viruses and DHR, to improve management of those patients.
引用
收藏
页数:10
相关论文
共 128 条
[1]   Cytopathic effects: virus-modulated manifestations of innate immunity? [J].
Agol, Vadim I. .
TRENDS IN MICROBIOLOGY, 2012, 20 (12) :570-576
[2]  
Ahluwalia J, 2015, BRIT J DERMATOL, V172, P1090, DOI 10.1111/bjd.13512
[3]   Danger: the view from the bottom of the cliff [J].
Anderson, CC ;
Matzinger, P .
SEMINARS IN IMMUNOLOGY, 2000, 12 (03) :231-238
[4]   Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein Tat [J].
Arp, J ;
Rieder, MJ ;
Urquhart, B ;
Freeman, D ;
Tucker, MJ ;
Krizova, A ;
Lehmann, D ;
Dekaban, GA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03) :1218-1225
[5]   Cytomegalovirus Disease During Severe Drug Eruptions Report of 2 Cases and Retrospective Study of 18 Patients With Drug-Induced Hypersensitivity Syndrome [J].
Asano, Yusuke ;
Kagawa, Hiroaki ;
Kano, Yoko ;
Shiohara, Tetsuo .
ARCHIVES OF DERMATOLOGY, 2009, 145 (09) :1030-1036
[6]   Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up [J].
Atanaskovic-Markovic, Marina ;
Gaeta, Francesco ;
Medjo, Biljana ;
Gavrovic-Jankulovic, Marija ;
Velickovic, Tanja Cirkovic ;
Tmusic, Vladimir ;
Romano, Antonino .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2016, 27 (05) :533-538
[7]   EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation [J].
Banerjee, Shuvomoy ;
Lu, Jie ;
Cai, Qiliang ;
Sun, Zhiguo ;
Jha, Hem Chandra ;
Robertson, Erle S. .
PLOS PATHOGENS, 2014, 10 (08)
[8]   Primary varicella infection associated with Stevens-Johnson syndrome in a Turkish child [J].
Bay, A ;
Akdeniz, N ;
Çalka, Ö ;
Kösem, M ;
Öner, AF ;
Dogan, M .
JOURNAL OF DERMATOLOGY, 2005, 32 (09) :745-750
[9]   Drug- and Virus- or Bacteria- induced Exanthems: The Role of Immunohistochemical Staining for Cytokines in Differential Diagnosis [J].
Bellini, Veronica ;
Pelliccia, Simona ;
Lisi, Paolo .
DERMATITIS, 2013, 24 (02) :85-90
[10]  
Bigby M, 2001, ARCH DERMATOL, V137, P765